|
1.
|
Parkin DM, Bray F, Ferlay J, et al: Global
cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2.
|
Schena M, Shalon D, Davis RW, et al:
Quantitative monitoring of gene expression patterns with a
complementary DNA microarray. Science. 270:467–470. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Lau WY, Lai PB, Leung MF, et al:
Differential gene expression of hepatocellular carcinoma using cDNA
microarray analysis. Oncol Res. 12:59–69. 2002.PubMed/NCBI
|
|
4.
|
Wang DG, Fan JB, Siao CJ, et al:
Large-scale identification, mapping and genotyping of
single-nucleotide polymorphisms in the human genome. Science.
280:1077–1082. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Kanda M, Nomoto S, Okamura Y, et al:
Detection of metallothionein 1G as a methylated tumor suppressor
gene in human hepatocellular carcinoma using a novel method of
double combination array analysis. Int J Oncol. 35:477–483.
2009.
|
|
6.
|
Okamura Y, Nomoto S, Kanda M, et al:
Leukemia inhibitory factor receptor (LIFR) is detected as a novel
suppressor gene of hepatocellular carcinoma using
double-combination array. Cancer Lett. 289:170–177. 2010.
View Article : Google Scholar
|
|
7.
|
Nomoto S, Kanda M, Okamura Y, et al:
Epidermal growth factor-containing fibulin-like extracellular
matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in
hepatocellular carcinoma using double combination array analysis.
Ann Surg Oncol. 17:923–932. 2010. View Article : Google Scholar
|
|
8.
|
Okamura Y, Nomoto S, Kanda M, et al:
Reduced expression of reelin (RELN) gene is associated with high
recurrence rate of hepatocellular carcinoma. Ann Surg Oncol.
18:572–579. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kanda M, Nomoto S, Okamura Y, et al:
Promoter hypermethylation of fibulin 1 gene is associated with
tumor progression in hepatocellular carcinoma. Mol Carcinog.
50:571–579. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hayashi M, Nomoto S, Kanda M, et al:
Identification of the A kinase anchor protein 12 (AKAP12) gene as a
candidate tumor suppressor of hepatocellular carcinoma. J Surg
Oncol. 105:381–386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Taira S and Yokoyama K: Self-assembly
DNA-conjugated polymer for detection of single nucleotide
polymorphism. Biotechnol Bioeng. 88:35–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Bibikova M and Fan JB: GoldenGate assay
for DNA methylation profiling. Methods Mol Biol. 507:149–163. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Okamura Y, Nomoto S, Hayashi M, et al:
Identification of the bleomycin hydrolase gene as a methylated
tumor suppressor gene in hepatocellular carcinoma using a novel
triple-combination array method. Cancer Lett. 312:150–157. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Shimizu I: Impact of oestrogens on the
progression of liver disease. Liver Int. 23:63–69. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
DiMartino V, Lebray P, Myers RP, et al:
Progression of liver fibrosis in women infected with hepatitis C:
long-term benefit of estrogen exposure. Hepatology. 40:1426–1433.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Naugler WE, Sakurai T, Kim S, et al:
Gender dis:parity in liver cancer due to sex differences in
MyD88-dependent IL-6 production. Science. 317:121–124. 2007.
View Article : Google Scholar
|
|
18.
|
Omoya T, Shimizu I, Zhou Y, et al: Effects
of idoxifene and estradiol on NF-kappaB activation in cultured rat
hepatocytes undergoing oxidative stress. Liver. 21:183–191. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Teng J, Wang ZY, Jarrard DF, et al: Roles
of estrogen receptor α and β in modulating urothelial cell
proliferation. Endocr Relat Cancer. 15:351–364. 2008.
|
|
20.
|
Danel L, Cordier G, Revillard JP, et al:
Presence of estrogen binding sites and growth-stimulating effect of
estradiol in the human myelogenous cell line HL60. Cancer Res.
42:4701–4705. 1982.PubMed/NCBI
|
|
21.
|
Hatfill SJ, Brusnicky J and Fester E:
Immunocytochemical identification of nuclear estrogen-receptors in
human acute myeloid leukemia. Leuk Res. 15:315–320. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Holst F, Stahl PR, Ruiz C, et al: Estrogen
receptor alpha (ESR1) gene amplification is frequent in breast
cancer. Nat Genet. 39:655–660. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Pancholi S, Lykkesfeldt AE, Hilmi C, et
al: ERBB2 influences the subcellular localization of the estrogen
receptor in tamoxifen-resistant MCF-7 cells leading to the
activation of AKT and RPS6KA2. Endocr Relat Cancer. 15:985–1002.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Boix L, Bruix J, Castells A, et al: Sex
hormone receptors in hepatocellular carcinoma. Is there a rationale
for hormonal treatment? J Hepatol. 17:187–191. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
van’t Veer LJ, Dai H, van de Vijver MJ, et
al: Gene expression profiling predicts clinical outcome of breast
cancer. Nature. 415:530–536. 2002.PubMed/NCBI
|
|
26.
|
van’t Veer LJ, Dai H, van de Vijver MJ, et
al: Expression profiling predicts outcome in breast cancer. Breast
Cancer Res. 5:57–58. 2003.PubMed/NCBI
|
|
27.
|
Archer KJ, Mas VR, Maluf DG, et al:
High-throughput assessment of CpG site methylation for
distinguishing between HCV-cirrhosis and HCV-associated
hepatocellular carcinoma. Mol Genet Genomics. 283:341–349. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Maynadier M, Nirde P, Ramirez JM, et al:
Role of estrogens and their receptors in adhesion and invasiveness
of breast cancer cells. AdvExp Med Biol. 617:485–491. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ikai I, Itai Y, Okita K, et al: Report of
the 15th follow-up survey of primary liver cancer. Hepatol Res.
28:21–29. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mizoguchi Y, Takeda H, Kobayashi K, et al:
Impairment in the response of peripheral blood mononuclear cells
from asymptomatic hepatitis B virus carriers to estradiol. Jpn J
Med. 27:183–186. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Mizoguchi Y, Takeda H, Sakagami Y, et al:
Estradiol receptors in the cytosol of peripheral blood mononuclear
cells in hepatitis B virus carriers treated with interferon-alpha.
Gastroenterol Jpn. 24:373–379. 1989.PubMed/NCBI
|
|
32.
|
Wang SH, Yeh SH and Lin WH: Estrogen
receptor α represses transcription of HBV genes via interaction
with hepatocyte nuclear factor 4α. Gastroenterology. 142:989–998.
2012.
|
